Effect of small vessel disease burden and lacunes on gait/posture impairment in Parkinson's disease

被引:23
|
作者
Chen, Huimin [1 ,2 ,3 ]
Zhang, Meimei [1 ,2 ,3 ]
Liu, Gengliang [1 ,2 ,3 ]
Wang, Xuemei [1 ,2 ,3 ]
Wang, Zhan [1 ,2 ,3 ]
M, Huizi [1 ,2 ,3 ]
Pan, Yuesong [1 ,2 ,3 ]
Wang, David [4 ]
Wang, Yilong [1 ,2 ,3 ]
Feng, Tao [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[2] China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing, Peoples R China
[3] Capital Med Univ, Adv Innovat Ctr Human Brain Project, Beijing, Peoples R China
[4] Univ Illinois, Coll Med, Illinois Neurol Inst Stroke Network, Sisters Third Order St Francis Healthcare Syst, Peoria, IL 61656 USA
基金
中国国家自然科学基金;
关键词
Cerebral small vessel disease; Lacunae; Parkinson's disease; Gait; WHITE-MATTER LESIONS; FUNCTIONAL-ANATOMY; VASCULAR-DISEASE; RISK-FACTORS; MOTOR; SYMPTOMS; MRI; LEVODOPA;
D O I
10.1007/s10072-020-04452-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The comorbidity of cerebral small vessel disease (CSVD) may worsen gait impairment of Parkinson's disease (PD). However, the evidence remains scarce and controversial, and the mechanism of their potential interaction remains largely unknown. The present study aimed to investigate the overall impact of quantity and location of CSVD on gait/posture function in PD. Methods This cross-sectional study included 315 consecutive eligible patients with PD from Beijing Tiantan Hospital from May 2016 to August 2018. Associations of gait/posture subscores with the burden score of CSVD and four CSVD imaging markers were assessed using multivariate linear regression models. Results Burden of CSVD was significantly associated with more severe gait/posture impairment in PD in the unadjusted model (beta = 0.521, P = 0.011, 95% CI 0.118-0.923) and in the model adjusted for age, hypertension, ischemic stroke, low-density lipoprotein level, cholesterol level, and cognitive statues (beta = 0.448, P = 0.047, 95% CI 0.006-0.891). The presence of lacunes, but not other CSVD markers, was significantly associated with higher gait/posture subscores after the adjustment (beta = 0.492, P = 0.041, 95% CI 0.021-0.964), and the number of lacunes in the basal ganglia significantly correlated with the gait/posture subscores in patients with PD (P = 0.012, Spearman r = 0.161). Conclusions CSVD and lacunes in the basal ganglia may independently contribute to gait/posture dysfunction in PD. Promoting neurovascular health may preserve some gait/posture function of PD.
引用
收藏
页码:3617 / 3624
页数:8
相关论文
共 50 条
  • [41] Cholinergic nucleus 4 atrophy and gait impairment in Parkinson’s disease
    W. Alex Dalrymple
    Diane S. Huss
    Jamie Blair
    Joseph L. Flanigan
    James Patrie
    Scott A. Sperling
    Binit B. Shah
    Madaline B. Harrison
    T. Jason Druzgal
    Matthew J. Barrett
    Journal of Neurology, 2021, 268 : 95 - 101
  • [42] Freezing of gait in Parkinson's disease: a perceptual cause for a motor impairment?
    Almeida, Q. J.
    Lebold, C. A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (05): : 513 - 518
  • [43] Circadian dysfunction and fluctuations in gait initiation impairment in Parkinson's disease
    Stewart, Julianne
    Bachman, Gail
    Cooper, Clarissa
    Liu, Lianqi
    Ancoli-Israel, Sonia
    Alibiglou, Laila
    EXPERIMENTAL BRAIN RESEARCH, 2018, 236 (03) : 655 - 664
  • [44] Circadian dysfunction and fluctuations in gait initiation impairment in Parkinson’s disease
    Julianne Stewart
    Gail Bachman
    Clarissa Cooper
    Lianqi Liu
    Sonia Ancoli-Israel
    Laila Alibiglou
    Experimental Brain Research, 2018, 236 : 655 - 664
  • [45] Gait impairment is more than a motor symptom in Parkinson's disease
    Chan, H. F.
    Chau, D. K. W.
    Fung, T.
    Cheung, Y. F.
    Fong, W. C.
    MOVEMENT DISORDERS, 2016, 31 : S246 - S246
  • [46] Gait Impairment in Mexican Patients with Parkinson's disease: A Transversal Study
    Castillo, Sergio
    Cerda-Contreras, Christopher
    Estrada Bellmann, Ingrid
    MOVEMENT DISORDERS, 2018, 33 : S23 - S24
  • [47] Cholinergic nucleus 4 atrophy and gait impairment in Parkinson's disease
    Dalrymple, W. Alex
    Huss, Diane S.
    Blair, Jamie
    Flanigan, Joseph L.
    Patrie, James
    Sperling, Scott A.
    Shah, Binit B.
    Harrison, Madaline B.
    Druzgal, T. Jason
    Barrett, Matthew J.
    JOURNAL OF NEUROLOGY, 2021, 268 (01) : 95 - 101
  • [48] Gait in Parkinson's Disease
    Martinez-Ramirez, Daniel
    Rodriguez-Violante, Mayela
    Ramirez-Zamora, Adolfo
    PARKINSONS DISEASE, 2019, 2019
  • [49] Gait impairment as predictor of falls in patients with early Parkinson's disease
    Stankovic, I.
    Markovic, V.
    Radovanovic, S.
    Petrovic, I.
    Dragasevic, N.
    Svetel, M.
    Stefanova, E.
    Kostic, V.
    MOVEMENT DISORDERS, 2021, 36 : S438 - S438
  • [50] Progression of small vessel disease correlates with cortical thinning in Parkinson's disease
    Foo, Heidi
    Mak, Elijah
    Yong, Ting Ting
    Wen, Ming-Ching
    Chander, Russell Jude
    Au, Wing Lok
    Tan, Louis
    Kandiah, Nagaendran
    PARKINSONISM & RELATED DISORDERS, 2016, 31 : 34 - 40